Clinical Trials Directory

Trials / Completed

CompletedNCT03686982

The Impact of Supplementation With Novel Prototype Nutrition Bar on Nitric Oxide Bioavailability and Measures of Athlete Performance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
PepsiCo Global R&D · Industry
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Dietary nitrate, L-citrulline, epicatechin, vitamin C and glutathione have the potential to improve nitric oxide (NO) bioavailability, in humans, by influencing both the nitrate-nitrite-NO and NO synthase-dependent pathways, and the storage of NO. The study is designed to assess the efficacy of a newly developed product containing a mixture of these compounds. Specifically, the study will assess if the product is capable of increasing NO bioavailability and if this results in positive effects on exercise economy and intermittent exercise performance. These outcome measures have been chosen because they have previously been positively impacted by an increase in NO bioavailability.

Conditions

Interventions

TypeNameDescription
OTHERActive Nitrate BarBar containing Nitrate, L-citrulline; epicatechin; vitamin C and glutathione
OTHERPlacebo BarNo active ingredients

Timeline

Start date
2017-05-01
Primary completion
2018-04-15
Completion
2018-04-30
First posted
2018-09-27
Last updated
2018-09-27

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03686982. Inclusion in this directory is not an endorsement.